• 11 DE
• 12 EN

• 9 Home
• 10 Contact
• 11 Sitemap

Imprint

Merz Pharmaceuticals GmbH
Eckenheimer Landstrasse 100-104
60318 Frankfurt am Main
Germany

Phone: +49 - (0)69 / 15 0 - 31
Fax: +49 - (0)69 / 5 96 21 50
E-Mail: contact@merz.de

Management:

Dr. Martin Zügel, Chief Executive Officer
Dr. Alexander Gebauer, Research & Development
Dr. Karsten Schlemm, Marketing & Sales International
Dr. Eugen Wilbert, Marketing & Sales Germany

Commercial Register:
District Court at Frankfurt am Main,
HRB 54072,
USt.Id.-Nr. DE813402137

Contents:

Merz Pharmaceuticals
Dr. Astrid Glaser

Concept, Design & Programming:

GPM Gesellschaft für PräsentationsMedien mbH
Westerbachstraße 47
60489 Frankfurt am Main
Germany

Phone: +49 - (0)69 / 40 58 60 - 30
Fax: +49 - (0)69 / 40 58 60 - 59
Email: info@gpm.de
Web: www.gpm.de

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

Marketing authorisation

• At this time Xeomin® is approved in Austria, Canada, Germany, Denmark, Finland, France, Italy, UK, Luxembourg, Norway, Poland, Portugal, Spain, Sweden, Argentinia and Mexico.